Jong W Kim

7943587, May 17, 2011

May 6, 2002

10/139423

David B. Weiner - Merion Station PA, US
Jong J. Kim - North Wales PA, US
Michael G. Agadjanyan - Huntington Beach CA, US

A61K 48/00
C12N 15/63

514 44R, 4353201

Methods of inducing an immune response against an immunogen in an individual are disclosed. The methods comprise administering to the individual, one or more nucleic acid molecules that comprise a nucleotide sequence that encodes an immunogen and a nucleotide sequence that encodes an Major Histocompatibility Complex antigen. The nucleotide sequences that encode the immunogen and the Major Histocompatibility Complex antigen are expressed when taken up by cells of the individual and an immune response against the immunogen is induced in the individual. Methods of reducing rejection of unmatched donor cells, tissue or organ in an individual undergoing cell, tissue or organ transplantation are disclosed. The methods comprise administering to the individual, one or more nucleic acid molecules that comprise a nucleotide sequence that encodes a death signal or toxin and a nucleotide sequence that encodes a Major Histocompatibility Complex antigen that is matched to the donor cells, tissue or organ. The nucleotide sequences that encode the Major Histocompatibility Complex antigen and death signal or toxin are expressed when taken up by cells of the individual.

8119395, Feb 21, 2012

Feb 26, 1999

09/622452

David B. Weiner - Merion Station PA, US
Jong J. Kim - North Wales PA, US
Jeong-Im Sin - Seoul, KR

The Trustees of The University of Pennsylvania - Philadelphia PA

C12N 15/85
A61K 48/00
C12N 15/33

4353201, 514 44 R

Improved vaccines which include a nucleotide sequence that encodes immunomodulating protein operably linked to regulatory elements are disclosed. The improved vaccines include DNA vaccines, recombinant vaccines for delivering foreign antigen and live attenuated vaccines. Methods of immunizing individuals are disclosed. Compositions for and methods of treating individuals with autoimmune diseases are disclosed.

8565384, Oct 22, 2013

Jan 28, 2008

12/524034

Henning G. Schulzrinne - Leonia NJ, US
Wonsang Song - New York NY, US
Jong Yul Kim - New York NY, US

The Trustees of Columbia University in the City of New York - New York NY

H04M 11/00

379 52, 455416

Systems, methods, and media for connecting emergency communications are provided. For example, the methods can include: receiving an emergency communication at a particular public safety answering point from a caller directed to the particular public safety answering point by a location-to-service system; creating a conference on a conference system in response to the particular public safety answering point accepting the emergency communication; selecting a particular call-taker of a plurality of call-takers; sending the particular call-taker an invitation to accept the emergency communication; in response to receiving an indication that the particular call-taker has accepted the emergency communication, connecting the selected call-taker to the conference; connecting the caller to the conference; determining the location of the caller; querying the location-to-service system to identify at least one particular emergency responder of a plurality of emergency responders; and connecting at least one of the at least one particular emergency responder to the conference.

20050201986, Sep 15, 2005

May 6, 2005

11/123600

David Weiner - Merion PA, US
Jong Kim - North Wales PA, US
Donghui Zhang - Philadelphia PA, US

A61K009/127
A61K048/00
C12N015/86

424093200, 435456000, 424450000

Drug delivery compositions and methods of delivering compounds to specific cell types are disclosed. Vaccines and methods of immunizing individuals are disclosed. Compositions for drug delivery including gene therapy and methods of treating individuals using such compositions are disclosed.

20070259014, Nov 8, 2007

Jun 21, 2004

10/561603

Jong Kim - North Wales PA, US

VGX PHARMACEUTICALS, INC. - Blue Bell PA

A61K 9/70
A61K 31/075
A61K 31/10
A61K 31/425
A61K 31/445
A61K 31/497
A61K 31/505
A61K 31/535
A61K 31/55
A61K 31/56
A61P 31/18
A61K 31/58
A61K 31/655
A61K 31/66
A61K 31/70
A61K 35/74
A61K 38/21
A61K 9/00

424402000, 424425000, 424486000, 424780000, 424085700, 514120000, 514150000, 514172000, 514177000, 514179000, 514220000, 514230500, 514253010, 514256000, 514026000, 514274000, 514328000, 514365000, 514709000, 514716000

Pharmaceutical composition comprising compounds and/or compositions useful to inhibit HIV replication are disclosed. Methods of treating individuals infected with HIV are disclosed. Methods of preventing HIV infection in high risk individuals are disclosed.

20070259844, Nov 8, 2007

Jun 21, 2004

10/561656

Jong Kim - North Wales PA, US

VGX PHARMACEUTICALS - Blue Bell PA

A61K 31/573
A61K 38/21
A61K 31/7056
A61K 31/551
A61K 31/522

514179000, 424085700, 514043000, 514263310, 514220000

Pharmaceutical compositions for and methods of preventing infection or treating an individual who has been identified as being infected with a Flavivirus, Pestivirus, picornovirus or coronavirus such as HCV, GB virus B, JEV, WNV, CSFV, BDV, BVDV, poliovirus, FMDV, or EMCV, comprising administering to the individual a therapeutically effective amount of one or more glucocorticoid receptor antagonist compounds, wherein said compound has steroidal structure are disclosed.

20120195852, Aug 2, 2012

Jan 27, 2012

13/360389

David B. Weiner - Merion PA, US
Jong J. Kim - North Wales PA, US
Jeong-Im Sin - Chuncheon-City, KR

A61K 38/20
A61K 39/00
A61K 39/245
A61K 39/21
A61K 38/19
C07K 16/24
C07K 16/28
C07K 16/40
C07K 16/18
A61K 39/395
A61P 37/06
A61P 37/04
A61P 31/18
A61P 35/00
A61P 31/22
A61P 31/00
C12N 15/63

424 852, 4353201, 4241841, 4242311, 4242771, 4242081, 4241991, 424 851, 5303892, 5303896, 5303891, 5303893, 4241581, 4241721, 4241731

Improved vaccines which include a nucleotide sequence that encodes immunomodulating protein operably linked to regulatory elements are disclosed. The improved vaccines include DNA vaccines, recombinant vaccines for delivering foreign antigen and live attenuated vaccines. Methods of immunizing individuals are disclosed. Compositions for and methods of treating individuals with autoimmune diseases are disclosed.

20140023064, Jan 23, 2014

Sep 19, 2013

14/031582

Henning G. Schulzrinne - Leonia NJ, US
Wonsang Song - New York NY, US
Jong Yul Kim - New York NY, US

The Trustees of Columbia University in the City of New York - New York NY

H04L 29/08

370352

Systems, methods, and media for connecting emergency communications are provided. For example, the methods can include: receiving an emergency communication at a particular public safety answering point from a caller directed to the particular public safety answering point by a location-to-service system; creating a conference on a conference system in response to the particular public safety answering point accepting the emergency communication; selecting a particular call-taker of a plurality of call-takers; sending the particular call-taker an invitation to accept the emergency communication; in response to receiving an indication that the particular call-taker has accepted the emergency communication, connecting the selected call-taker to the conference; connecting the caller to the conference; determining the location of the caller; querying the location-to-service system to identify at least one particular emergency responder of a plurality of emergency responders; and connecting at least one of the at least one particular emergency responder to the conference.